News tagged with research and development
Study IDs key protein for cell death, offers way to kill cancer cells by forcing them into programmed-death pathway
When cells suffer too much DNA damage, they are usually forced to undergo programmed cell death, or apoptosis. However, cancer cells often ignore these signals, flourishing even after chemotherapy drugs have ...
Genetics
May 14, 2013 |
5 / 5 (9) |
0
|
Pertactin-negative Bordetella pertussis identified in U.S.
(HealthDay)—Pertactin-negative variants of Bordetella pertussis have been identified in the United States; and children who receive diphtheria-tetanus-whole-cell pertussis (DTwP) priming have lower report ...
Diseases, Conditions, Syndromes
Feb 07, 2013 |
not rated yet |
0
Embryo-analysis technique may boost in vitro fertilization success
(Medical Xpress)—Stanford University School of Medicine researchers have devised a two-part approach to identify developing human embryos most likely to result in successful pregnancies. The technique could transform the ...
Obstetrics & gynaecology
Dec 05, 2012 |
not rated yet |
0
|
GlaxoSmithKline says Q3 net profits drop 18.5%
British drugmaker GlaxoSmithKline said Wednesday that third-quarter net profits fell 18.5 percent from a year earlier to £1.12 billion ($1.80 billion, 1.39 billion euros), hit by weak conditions in Europe.
Other
Nov 01, 2012 |
not rated yet |
0
Researchers reveal how Trop2 protein drives tumor growth in prostate, other epithelial cancers
(Medical Xpress)—Researchers led by Tanya Stoyanova and Dr. Owen Witte of UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have determined how a protein known as Trop2 drives the growth ...
Cancer
Oct 16, 2012 |
not rated yet |
0
|
Japanese firm buys US pharmaceutical company
(AP)—A Japanese pharmaceutical company is acquiring LigoCyte Pharmaceuticals in a $60 million deal to expand its vaccine division, Takeda Pharmaceutical Co. announced.
Medications
Oct 05, 2012 |
not rated yet |
0
Valeant agrees to pay about $2.6B for Medicis
(AP)—Valeant Pharmaceuticals International Inc. has agreed to buy dermatology products maker Medicis Pharmaceutical Corp. for about $2.6 billion in cash in a deal to strengthen its position in skin treatments and care.
Medications
Sep 03, 2012 |
not rated yet |
0
Merck KGaA suffers setback on cancer drug
German pharmaceuticals maker Merck KGaA said Thursday that phase III clinical trials of its gastric cancer drug Erbitux had shown no benefits for patients.
Cancer
Jul 05, 2012 |
not rated yet |
0
Cancer drugs: better, cheaper
Cancer drug development is known to be too slow, costly and fraught with failure. Now the U.S. Food and Drug Administration is issuing recommendations for breast cancer trials that would substantially accelerate patient access ...
Cancer
Jun 04, 2012 |
not rated yet |
0
Increase in physical activity in men optimizes peak bone mass
(HealthDay) -- For young men, increasing physical activity over a five-year period is associated with improvements in bone mineral content (BMC) and bone mineral density (BMD), according to a study published ...
Health
May 21, 2012 |
not rated yet |
0
An international treaty is needed to improve medical research worldwide
An international treaty is a promising tool for improving the coherence, fairness, efficiency, and sustainability of the global health research and development system according to international experts writing in this week's ...
Medical research
May 15, 2012 |
not rated yet |
0
World Health Assembly should adopt an international convention on global health R&D: Expert group
The expert working group advising WHO on research and development has recommended the May 2012 World Health Assembly adopt an international convention on research and development (R&D) that will bind member states to action ...
Health
May 15, 2012 |
not rated yet |
0
New report warns of setbacks in global health progress due to current budget climate
The prospect of deep cuts in the federal budget threatens to reverse the dramatic progress of a bipartisan US commitment to defeat neglected diseases in developing countries, according to a new report released today by the ...
Health
Feb 28, 2012 |
not rated yet |
0
The respective roles of the public and private sectors in pharmaceutical innovation
The study identifies the respective contributions of direct and indirect government support in research and development of new pharmaceutical drugs.
Medications
Dec 15, 2011 |
not rated yet |
0
Researchers discover mechanism in brain cancer responsible for neuron death
Researchers from Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine have discovered a mechanism by which glioblastoma multiforme (GBM), the most common form of brain cancer, ...
Medical research
Nov 03, 2011 |
not rated yet |
0
